Nuzenio

Rituximab Biosimilar

Rituximab Biosimilar news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 19 latest news signals 18 publisher sources 100/100 entity strength

Latest news

Biosimilar therapy shows similar 6-month remission rates in AAV - ANCA Vasculitis NewsANCA Vasculitis News · Wed, 05 Aug 2026 19:11:57 GMTFDA Clears Rituximab Biosimilar, Expanding Options for B-Cell Malignancies - Targeted OncologyTargeted Oncology · Tue, 04 Aug 2026 20:10:58 GMTFDA Approves Rituximab Biosimilar Commercialized in US by Fresenius Kabi - Contract PharmaContract Pharma · Tue, 04 Aug 2026 18:43:31 GMTRituximab Biosimilars Show Similar 6-Month Outcomes to Originator in ANCA-Associated Vasculitis - MedscapeMedscape · Tue, 04 Aug 2026 14:40:15 GMTDr. Reddy's Laboratories rises on getting USFDA`s approval for rituximab biosimilar - Investment GuruInvestment Guru · Tue, 04 Aug 2026 05:55:08 GMTFresenius Announces FDA Approval of Rituximab Biosimilar for the U.S. Market - Business WireBusiness Wire · Mon, 03 Aug 2026 20:09:00 GMTDr. Reddy’s Laboratories (NYSE: RDY) secures FDA approval for rituximab biosimilar - Stock TitanStock Titan · Mon, 03 Aug 2026 10:24:59 GMTDr. Reddy's Rituximab biosimilar gets approval from US FDA - Indian Pharma PostIndian Pharma Post · Mon, 03 Aug 2026 06:22:07 GMT

Timeline

Wed, 05 Aug 2026 19:11:57 GMTBiosimilar therapy shows similar 6-month remission rates in AAV - ANCA Vasculitis News
Tue, 04 Aug 2026 20:10:58 GMTFDA Clears Rituximab Biosimilar, Expanding Options for B-Cell Malignancies - Targeted Oncology
Tue, 04 Aug 2026 18:43:31 GMTFDA Approves Rituximab Biosimilar Commercialized in US by Fresenius Kabi - Contract Pharma
Tue, 04 Aug 2026 14:40:15 GMTRituximab Biosimilars Show Similar 6-Month Outcomes to Originator in ANCA-Associated Vasculitis - Medscape
Tue, 04 Aug 2026 05:55:08 GMTDr. Reddy's Laboratories rises on getting USFDA`s approval for rituximab biosimilar - Investment Guru
Mon, 03 Aug 2026 20:09:00 GMTFresenius Announces FDA Approval of Rituximab Biosimilar for the U.S. Market - Business Wire

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Rituximab Biosimilar.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

18 distinct publisher/source names are currently connected to this entity page.